Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Serum erythropoietin levels, breast cancer and breast cancer-initiating cells.

Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, Magyar CE, Du L, Li G, McCloskey S, Vlashi E, Pajonk F.

Breast Cancer Res. 2019 Jan 30;21(1):17. doi: 10.1186/s13058-019-1100-9.

2.

Different duration of parathyroid hormone exposure distinctively regulates primary response genes Nurr1 and RANKL in osteoblasts.

Choi H, Magyar CE, Nervina JM, Tetradis S.

PLoS One. 2018 Dec 21;13(12):e0208514. doi: 10.1371/journal.pone.0208514. eCollection 2018.

3.

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.

Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, Walser T, Yanagawa J, Aberle DR, Barrio JR, Dubinett SM, Shackelford DB.

Sci Transl Med. 2018 Nov 14;10(467). pii: eaat5933. doi: 10.1126/scitranslmed.aat5933.

PMID:
30429355
4.

Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication.

Lu NT, Liu NM, Patel D, Vu JQ, Liu L, Kim CY, Cho P, Khachatoorian R, Patel N, Magyar CE, Ganapathy E, Arumugaswami V, Dasgupta A, French SW.

J Cell Death. 2018 Jul 4;11:1179066018785141. doi: 10.1177/1179066018785141. eCollection 2018.

5.

The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice.

Hui ST, Kurt Z, Tuominen I, Norheim F, C Davis R, Pan C, Dirks DL, Magyar CE, French SW, Chella Krishnan K, Sabir S, Campos-Pérez F, Méndez-Sánchez N, Macías-Kauffer L, León-Mimila P, Canizales-Quinteros S, Yang X, Beaven SW, Huertas-Vazquez A, Lusis AJ.

Hepatology. 2018 Dec;68(6):2182-2196. doi: 10.1002/hep.30113. Epub 2018 Nov 8.

PMID:
29907965
6.

Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Henning SM, Galet C, Gollapudi K, Byrd JB, Liang P, Li Z, Grogan T, Elashoff D, Magyar CE, Said J, Cohen P, Aronson WJ.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):212-220. doi: 10.1038/s41391-017-0001-1. Epub 2017 Dec 4.

7.

Arctigenin inhibits prostate tumor cell growth in vitro and in vivo.

Wang P, Solorzano W, Diaz T, Magyar CE, Henning SM, Vadgama JV.

Clin Nutr Exp. 2017 Jun;13:1-11. doi: 10.1016/j.yclnex.2017.04.001. Epub 2017 Apr 8.

8.

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.

Grant DJ, Chen Z, Howard LE, Wiggins E, De Hoedt A, Vidal AC, Carney ST, Squires J, Magyar CE, Huang J, Freedland SJ.

BMC Cancer. 2017 Jul 3;17(1):463. doi: 10.1186/s12885-017-3463-6.

9.

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.

Wang P, Henning SM, Magyar CE, Elshimali Y, Heber D, Vadgama JV.

J Exp Clin Cancer Res. 2016 May 6;35:73. doi: 10.1186/s13046-016-0351-x.

10.

Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancer.

Jiao J, Ishikawa TO, Dumlao DS, Norris PC, Magyar CE, Mikulec C, Catapang A, Dennis EA, Fischer SM, Herschman HR.

Mol Cancer Res. 2014 Nov;12(11):1677-88. doi: 10.1158/1541-7786.MCR-14-0397-T. Epub 2014 Jul 25.

11.

Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.

Kroeger N, Seligson DB, Signoretti S, Yu H, Magyar CE, Huang J, Belldegrun AS, Pantuck AJ.

Eur J Cancer. 2014 May;50(8):1531-40. doi: 10.1016/j.ejca.2014.01.031. Epub 2014 Feb 21.

PMID:
24565854
12.

Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.

Wang P, Vadgama JV, Said JW, Magyar CE, Doan N, Heber D, Henning SM.

J Nutr Biochem. 2014 Jan;25(1):73-80. doi: 10.1016/j.jnutbio.2013.09.005. Epub 2013 Oct 10.

13.

Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.

An J, Liu H, Magyar CE, Guo Y, Veena MS, Srivatsan ES, Huang J, Rettig MB.

Cancer Res. 2013 Feb 15;73(4):1374-85. doi: 10.1158/0008-5472.CAN-12-2362. Epub 2013 Feb 7.

14.

Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.

Chen H, Sun Y, Wu C, Magyar CE, Li X, Cheng L, Yao JL, Shen S, Osunkoya AO, Liang C, Huang J.

Endocr Relat Cancer. 2012 May 24;19(3):321-31. doi: 10.1530/ERC-11-0368. Print 2012 Jun.

15.

Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting.

Alonso V, Magyar CE, Wang B, Bisello A, Friedman PA.

J Bone Miner Res. 2011 Dec;26(12):2923-34. doi: 10.1002/jbmr.494.

16.

Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy.

Guo S, Sun F, Guo Z, Li W, Alfano A, Chen H, Magyar CE, Huang J, Chai TC, Qiu S, Qiu Y.

PLoS One. 2011 Mar 7;6(3):e17778. doi: 10.1371/journal.pone.0017778.

17.

Considerations for uniform and accurate biospecimen labelling in a biorepository and research environment.

Kay AB, Estrada DK, Mareninov S, Silver SS, Magyar CE, Dry SM, Cloughesy TF, Yong WH.

J Clin Pathol. 2011 Jul;64(7):634-6. doi: 10.1136/jcp.2010.080655. Epub 2011 Jan 7.

PMID:
21217091
18.

The effect of three hemostatic agents on early bone healing in an animal model.

Armstrong JK, Han B, Kuwahara K, Yang Z, Magyar CE, Dry SM, Atti E, Tetradis S, Fisher TC.

BMC Surg. 2010 Dec 17;10:37. doi: 10.1186/1471-2482-10-37.

19.

Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.

Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, Huang J, Li LC.

Cancer Res. 2010 Dec 15;70(24):10182-91. doi: 10.1158/0008-5472.CAN-10-2414.

20.

Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.

Belanto JJ, Diaz-Perez SV, Magyar CE, Maxwell MM, Yilmaz Y, Topp K, Boso G, Jamieson CH, Cacalano NA, Jamieson CA.

Neuromuscul Disord. 2010 Feb;20(2):111-21. doi: 10.1016/j.nmd.2009.12.003. Epub 2010 Jan 18.

21.

Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma.

Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM.

Clin Cancer Res. 2009 Nov 15;15(22):6820-9. doi: 10.1158/1078-0432.CCR-09-1558. Epub 2009 Nov 3.

22.

Impaired renal calcium absorption in mice lacking calcium channel beta 3 subunits.

Bernardo JF, Magyar CE, Sneddon WB, Friedman PA.

Can J Physiol Pharmacol. 2009 Jul;87(7):522-30. doi: 10.1139/y09-035.

23.

Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing.

Magyar CE, Aghaloo TL, Atti E, Tetradis S.

Neurosurgery. 2008 Oct;63(4 Suppl 2):373-8; discussion 378. doi: 10.1227/01.NEU.0000316859.03788.44.

24.

PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts.

Nervina JM, Magyar CE, Pirih FQ, Tetradis S.

Bone. 2006 Nov;39(5):1018-1025. doi: 10.1016/j.bone.2006.04.023. Epub 2006 Jun 12.

PMID:
16765661
25.

Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.

Sneddon WB, Magyar CE, Willick GE, Syme CA, Galbiati F, Bisello A, Friedman PA.

Endocrinology. 2004 Jun;145(6):2815-23. Epub 2004 Mar 11.

PMID:
15016722
26.

Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).

Sneddon WB, Syme CA, Bisello A, Magyar CE, Rochdi MD, Parent JL, Weinman EJ, Abou-Samra AB, Friedman PA.

J Biol Chem. 2003 Oct 31;278(44):43787-96. Epub 2003 Aug 14.

27.

Plasma membrane Ca2+-ATPase and NCX1 Na+/Ca2+ exchanger expression in distal convoluted tubule cells.

Magyar CE, White KE, Rojas R, Apodaca G, Friedman PA.

Am J Physiol Renal Physiol. 2002 Jul;283(1):F29-40.

28.

Downstream shift in sodium pump activity along the nephron during acute hypertension.

Magyar CE, Zhang Y, Holstein-Rathlou NH, McDonough AA.

J Am Soc Nephrol. 2001 Nov;12(11):2231-40.

29.

Proximal tubule Na transporter responses are the same during acute and chronic hypertension.

Magyar CE, Zhang Y, Holstein-Rathlou NH, McDonough AA.

Am J Physiol Renal Physiol. 2000 Aug;279(2):F358-69.

30.

Molecular mechanisms of sodium transport inhibition in proximal tubule during acute hypertension.

Magyar CE, McDonough AA.

Curr Opin Nephrol Hypertens. 2000 Mar;9(2):149-56. Review.

PMID:
10757220
31.

In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition.

Zhang Y, Norian JM, Magyar CE, Holstein-Rathlou NH, Mircheff AK, McDonough AA.

Am J Physiol. 1999 May;276(5):F711-9. doi: 10.1152/ajprenal.1999.276.5.F711.

PMID:
10330053
32.

Reversible effects of acute hypertension on proximal tubule sodium transporters.

Zhang Y, Magyar CE, Norian JM, Holstein-Rathlou NH, Mircheff AK, McDonough AA.

Am J Physiol. 1998 Apr;274(4 Pt 1):C1090-100.

PMID:
9575807
33.
34.

Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis.

Zhang Y, Mircheff AK, Hensley CB, Magyar CE, Warnock DG, Chambrey R, Yip KP, Marsh DJ, Holstein-Rathlou NH, McDonough AA.

Am J Physiol. 1996 Jun;270(6 Pt 2):F1004-14. Erratum in: Am J Physiol 1996 Oct;271(4 Pt 2): section F following table of contents. Am J Physiol 1996 Dec;271(6 Pt 3):section F followi.

PMID:
8764320
35.

Renal Na+/H+ exchanger isoforms and their regulation by thyroid hormone.

Azuma KK, Balkovetz DF, Magyar CE, Lescale-Matys L, Zhang Y, Chambrey R, Warnock DG, McDonough AA.

Am J Physiol. 1996 Feb;270(2 Pt 1):C585-92.

PMID:
8779923
36.

Reciprocal regulation of cardiac Na-K-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development.

Magyar CE, Wang J, Azuma KK, McDonough AA.

Am J Physiol. 1995 Sep;269(3 Pt 1):C675-82.

PMID:
7573397
37.

Supplemental Content

Loading ...
Support Center